Aridis Pharmaceuticals, Inc. engages in the discovery and development of targeted immunotherapy using human monoclonal antibodies, or mAbs, to treat infections. The company was founded by Eric J. Patzer and Vu L. Truong on April 24, 2003 and is headquartered in Los Gatos, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Aridis Pharmaceuticals Inc market cap is $4,457.00.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Aridis Pharmaceuticals Inc 52 week high is $0.05 as of November 22, 2026.
Aridis Pharmaceuticals Inc stock price today is $0.0001.
Aridis Pharmaceuticals Inc stock price yesterday was $0.0001.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Aridis Pharmaceuticals Inc 50-day moving average is $0.0001.